🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

A Digitally-Enabled System for Precision Assessment and Intervention of Disability Risk in Older Adults

RecruitingNAAges 65 Years - anyAllSecond Affiliated Hospital, Zhejiang University, …
NCT07508813 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

1. Identify the primary risk factors for disability in older adults through multi-dimensional risk factor screening. 2. Develop a risk stratification model for disability in older adults by integrating outcome indicators and temporal characteristics, and construct an intelligent early warning model to enable automated assessment and monitoring of disability risk. 3. Establish key digital technologies for early warning and prevention of disability risk in older adults, and develop a whole-process digital intervention platform incorporating a decision support system for disability prevention management. 4. Create a digitally empowered hospital-community-household collaborative system for precise assessment and intervention of disability risk in older adults, achieving data-driven whole-process active disability management. The system will be demonstrated and evaluated in communities with d

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Community-dwelling permanent residents aged ≥65 years; * Able to operate a smartphone independently or with assistance from a primary caregiver; * Clear consciousness with basic comprehension and communication abilities; * Voluntarily agree to participate in the study and provide informed consent. Exclusion Criteria: * Those who are unable to perform basic activities of daily living independently, or who have significant cognitive or communication impairments.
💊

What it tests

  • Risk Assessment of Disability and Precision Intervention
📍

Where

1 site
The Second Affiliated Hospital of Medical College of Zhejiang University
Hangzhou, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy